Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening by Duncan, B. et al.
Papers
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Chlamydia trachomatis: implications for screening
Barbara Duncan, Graham Hart, Anne Scoular, Alison Bigrigg
Abstract
Objectives To investigate the psychosocial impact for
women of a diagnosis of Chlamydia trachomatis and
discuss the implications for the proposed UK
chlamydia screening programme.
Design Qualitative study with semistructured
interviews. Interview transcripts analysed to identify
recurrent themes.
Participants Seventeen women with a current or
recent diagnosis of chlamydia.
Setting A family planning clinic and a genitourinary
medicine clinic in Glasgow.
Results Three themes were identified: perceptions of
stigma associated with sexually transmitted infection,
uncertainty about reproductive health after diagnosis,
and anxieties regarding partner’s reaction to
diagnosis. Most women had not previously perceived
sexually transmitted infections as personally relevant;
this was a function of stereotypical beliefs about who
was “at risk” of sexually transmitted infection. These
beliefs were pervasive and negatively affected
reactions to diagnosis and produced anxiety about
disclosure of the condition to others (particularly
sexual partners) and future reproductive morbidity.
This anxiety, given the uncertain natural history of
chlamydia, may prove difficult to dispel.
Conclusions There are three primary areas of
concern for women after a diagnosis of chlamydia
which need to be examined in the proposed
screening programme. Information provided should
normalise and destigmatise chlamydial infection and
positively promote genitourinary medicine services.
Support services should be available because
notification of partner can cause anxiety. Uncertainty
about future reproductive morbidity may be
inevitable; staff providing screening will require
guidance in providing advice under such conditions.
Introduction
The sexually transmitted infection Chlamydia trachoma›
tis is a leading cause of reproductive morbidity in
women, including pelvic inflammatory disease and
infertility.1 Detection is difficult as it is largely
symptomatic. Screening has been shown to reduce the
prevalence of chlamydia in women2 and the incidence
of pelvic inflammatory disease.3 Currently, on the
recommendation of an expert advisory group to the
chief medical officer, two pilot studies are being under›
taken to assess the feasibility of implementing a
screening programme in the United Kingdom. A
major target group for screening would be young
women attending primary care providers.4
Women being screened will need information and
support and may experience psychosocial problems
associated with screening. Because of the complex
emotional investments and social taboos surrounding
sexual relationships5 reactions to a diagnosis of a sexu›
ally transmitted infection are likely to be complex.
Qualitative methods of research are appropriate for
such complex issues.6 7 We used these methods to
explore women’s experiences of diagnosis of C tracho›
matis and identify salient issues before the implementa›
tion of the pilot screening programmes. We investi›
gated the psychosocial impact of diagnosis and
discussed the implications of the results for the
proposed national screening programme.
Methods
Participants and recruitment
We recruited women with a current or recent diagnosis
of chlamydia who were currently attending either a
genitourinary medicine clinic or a family planning
clinic in central Glasgow. Women were either
approached directly by the researcher (BD) after their
consultation or treatment, or both, and invited to take
part, or approached by clinic staff, who obtained
written consent from women to release contact details
to the researcher. Written consent was obtained from
all women before interview, and ethical approval was
given by both health trusts involved.
The sample comprised the first 17 women who
agreed to participate (10 from the genitourinary medi›
cine clinic and seven from the family planning clinic;
response rate 62%). We considered this sampling
method appropriate because of the problems inherent
in recruitment to studies such as this and time
constraints. The mean time between treatment and
interview was 11 weeks, with the exception of one
woman who was awaiting the result of a recent chlamy›
dia test and who had been diagnosed with chlamydia
three years earlier. Women were aged between 18 and
29 years. Among women recruited in the genitourinary
medicine clinic, eight out of 10 had been referred by
other health providers. Women attending this clinic
were also more likely than women attending the family
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planning clinic to report symptoms relating to sexually
transmitted infection, although this could largely be
attributed to the presence of comorbidity (see box 1).
Interviews and analysis
All interviews were conducted by BD in a clinic setting
at the MRC Unit or in the women’s homes. Interviews
lasted between 40 minutes and two hours and were
tape recorded and transcribed verbatim. We used a
semistructured interview schedule, which explored
women’s experiences of being diagnosed with chlamy›
dia. Questions were open ended, and we adopted a
non›directive approach to encourage women to
develop and elaborate their own narratives about their
experiences (details of the interview schedule can be
found on the BMJ’s website).
Data were analysed with interpretative phenom›
enological analysis,8 which seeks to capture the mean›
ing to the participant of the phenomenon under
investigation. Individual transcripts were read repeat›
edly and then coded to identify emergent themes.
Recurrent themes were then identified across tran›
scripts; such themes reflect a shared understanding
among participants of the phenomena under investi›
gation. This was a dynamic process, with each
transcript informing both the collection of further data
and their subsequent analysis.9 BD carried out the
principal analysis. A subsample of transcripts was read
independently by GH and emergent and recurrent
themes discussed. The themes were agreed with AS
and AB.
Results
The themes that have implications for future screening
programmes were perceptions of stigma associated
with sexually transmitted infections, uncertainty about
future reproductive health, and anxieties regarding
male partners’ attitudes to diagnosis.
Stigma
Before diagnosis most participants had perceived
themselves as relatively invulnerable to infection. In the
women’s accounts, sexually transmitted infections were
associated with stereotypical notions of contamination
and delinquency. Participants distanced themselves
from the “type” of person likely to contract a sexually
transmitted infection (see box 2), which led them to
believe that chlamydia and other sexually transmitted
infections were not personally relevant. These stereo›
types also affected expectations of the genitourinary
medicine clinic, and initial reactions to referral were
generally negative. While six women reported some
knowledge of chlamydia before diagnosis, only two
acknowledged any sense of personal vulnerability to
infection. Of the eight women who had presented with
Box 1 Details of participants
Genitourinary medicine clinic
Reasons for attending clinic
Referred by: general practitioner (5), family planning
clinic (2), gynaecology services after termination of
pregnancy (1), sexual partner (2)
Employment status
Student (1), unemployed (1), financial management
(2), administrative/clerical (5), sales assistant (1)
Relationship status
Cohabiting (1), regular relationship (6), single (3)
Presenting symptoms and comorbidity (when present)
Abdominal pain (gonorrhoea) (1), genital warts (4),
abdominal pain (pelvic inflammatory disease) and
genital warts (1), irregular menstruation (1)
Family planning clinic
Reasons for attending clinic
Emergency contraception: requested sexual health
screen (1), advised to have sexual health screen (1),
referred by sexual partner (1), attended for sexual
health screen (1), seeking treatment for symptoms
related to sexually transmitted disease (1), insertion of
intrauterine device (1), cervical smear (1)
Employment status
Student (4), financial management (1),
administrative/clerical (1), care worker (1)
Relationship status
Regular relationship (5), single (2)
Presenting symptoms and comorbidity (when present)
Urinary symptoms (1)
Box 2 Perceptions of stigma associated with
sexually transmitted infections (place of
attendance in parentheses)
Feelings on initially attending the clinics
I was all very shy when I went in [to the clinic] I think.
When you go you feel—well, I felt really dirty because,
because it’s an STD [sexually transmitted disease]
basically and I thought people like me don’t get these
kind of things. (Respondent 2, family planning clinic)
Feelings of stigma associated with the genitourinary
medicine clinic
In all honesty, like I always imagined that [the clinic
was] like . . . this is terrible, this is totally judgmental,
but, like seedy, seedy people and people that are . . . not
prostitutes, I wouldn’t go as far as to say that, but just a
lot . . . that sort of place, you know, like filthy men go
and a lot of men sitting about. ‘Cos I mean, I don’t
sleep about and that’s why, like, why do I have to go to
one of these places, you know. I guess you have like a
preconceived idea about what it’s gonna be like and it
was totally fine. (Respondent 4, genitourinary medicine
clinic)
Reaction to diagnosis
BD: How did you feel?
A: Absolutely gob smacked . . . Totally shocked.
BD: When they [clinic staff] said they thought there
was something wrong, what did you think was wrong?
A: I don’t know. . . . that way I was I knew there was
something wrong but I suppose it was the kind of last
thing that you think about.
BD: Had you been having any symptoms or anything?
A: Uhuh, I’d been in like quite a bit of pain. (Respondent
1, genitourinary medicine clinic)
Disclosing diagnosis to others
You don’t phone up everyone and say I’ve got a
sexually transmitted disease you know, I’m not feeling
too good come round and see me, cheer me up . . .
From that point of view you feel very isolated because
you can’t really talk about it, I suppose you could but
you know other people’s reactions would put you off
talking about it. (Respondent 3, genitourinary medicine
clinic)
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symptoms associated with sexually transmitted infec›
tions, only four reported that, before attending a health
provider, they had correctly attributed their symptoms
to such an infection (one woman with urinary
symptoms, one with abdominal pain, one with
irregular menstruation, and one with genital warts).
For most women, therefore, receiving a diagnosis of
chlamydia was a shock, and all women reported
experiencing feelings that ranged from mild self
disgust to distress. Women also expressed worry about
disclosing their condition to others. Most did tell
selected friends or family members, but none did so
without some anxiety about negative reactions. Disclo›
sure to others functioned as a mechanism for
garnering social support, and feelings of isolation were
reported by women who felt unable to tell members of
their usual support network.
Future reproductive health
All of the women reported receiving verbal or written
information, or both, and advice from clinic staff about
chlamydial infection, treatment, and possible effects.
Provision of such information varied; all attenders of
genitourinary medicine clinics reported receiving
information and advice from health advisors, a service
not available to women attending the family planning
clinic. When participants were asked about the content
of such information, they most often recalled the
possibility of infertility after infection (see box 3). This
provoked a mixed reaction: relief that the infection had
been diagnosed and treated but also anxiety about
future reproductive morbidity. These anxieties were
exacerbated by clinical uncertainty about the natural
course of chlamydia and the difficulty of providing a
prognosis in relation to reproductive effects.1 The
largely asymptomatic nature of the infection (13 of the
women reported no related symptoms before diagno›
sis) meant that many of the participants were unsure
about the length of time that they had been infected.
As most women believed that there was a positive
association between duration of infection and prob›
ability of future infertility, this provided a further
source of continuing anxiety.
Anxieties about attitudes of male partners
Participants’ sexual relationships were mainly serially
monogamous, with some women having sex with
casual partners between relationships. For women with
chlamydia, guidelines suggest that all partners in the
past six months should be contacted.10 This relatively
long period of possible infectivity meant that women
often attributed the source of infection to a previous
relationship. Diagnosis of a sexually transmitted infec›
tion introduced the possibility of a current partner’s
infidelity, a possibility that could be discounted if the
source of infection was thought to be a previous
relationship. Clinic staff encouraged this belief; there
was wide variation in the reported likely duration of
infection (from a few weeks to seven years). Given this
variation, a plausible explanation is that health profes›
sionals were exploiting the uncertainty surrounding
the natural course of chlamydia infection to mitigate
the threat to the current relationship. Emphasis of the
uncertainty about duration of infection may lessen
fears about a partner’s infidelity but could also increase
anxiety about possible reproductive morbidity.
Despite the norm of serial monogamy among par›
ticipants and, reportedly, their partners, disclosure was
associated with fears of negative reactions by sexual
partners. Feelings of guilt, regret, and “dirtiness” were
also reported in this context. While disclosure did not
seriously threaten the current, regular relationships of
the women interviewed here, their fears of partners’
Box 3 Future reproductive health
Assessing the probability of future infertility
So when I got a letter [with the positive diagnosis] it
was a shock. I was worried . . . it was the fact that it can
make you infertile and when I had been to the doctor
and I had asked her about pelvic inflammatory
disease—like do you know if you have got it, like is
there anyway to know how advanced chlamydia has
got? And she said no not really until you start trying to
conceive and you can’t conceive that is when you
discover, and I thought God—is this going to be the
unknown thing until I’m trying to have a baby. The
fact that I knew when I had contracted it—I thought
maybe that would maybe give a timescale or an
indication of whether or not it was likely to have done
any damage, but she couldn’t say . . . I just said, you
know, do you know if you have got pelvic
inflammatory disease, it was the nurse that I was
speaking to at this point and she said . . . not always . . .
So anyway I don’t know . . . the things that I was
worried about she [the doctor] didn’t seem to give me
any answers on. (Respondent 4, family planning clinic)
Box 4 Anxieties about male partners’ attitudes
to diagnosis
Informing a current partner
It wasn’t a very pleasant experience . . . that I think
what hurt him more was the fact that I hadn’t told him
[about a previous partner], [he was] just very shocked.
I don’t know, he didn’t like the idea of me having slept
with too many people. But I tried to explain what
happened and he understood . . . I felt bad, I still feel
bad about it but I felt really bad that night and the
following day I just couldn’t think of anything else. I
felt just guilt more than anything else, regret. I
regretted it [previous partner] at the time and then the
fact I’ve harmed him [current partner] as well just
made it worse. (Respondent 1, family planning clinic)
Informing a former partner
Em . . . I don’t really know how to put it because we
had been on bad terms he [former partner] had made
life hell, you know and I had just been trying to
extricate myself from it. So I hadn’t really had any
contact with him, but I just said I had been told I had
this and like how long I have had it for and it was
possible that it would cause infertility, and he shouted
and bawled saying are you trying to say that I gave it to
you . . . So it was very tough to tell him but he was fine.
(Respondent 4, family planning clinic)
Feeling unable to inform a former partner
. . . things had ended very badly . . . and no, I couldn’t
have approached him on anything—for a cup of
tea—never mind something like that, you know . . .
under the circumstances I did want to go back to
previous partners and say, because I think that it’s
important that you do. And I had dreadful guilt, oh my
goodness what if I’ve passed this on to somebody else
and some other poor woman can’t have children
because I’ve not had the guts to go and say. (Respondent
7, family planning clinic)
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reactions were real and a considerable source of worry
(see box 4). Informing a previous partner was
perceived as difficult, especially when that relationship
had ended badly. Some women chose not to notify
former partners; this decision could also have psycho›
logical costs for women, such as feelings of guilt at their
perceived “irresponsibility.”
Discussion
Our results identified three primary areas of concern
after a diagnosis of chlamydia: the perceived stigma of
sexually transmitted infections, worry about future
reproductive health, and anxiety associated with
notifying partners. Our results have several implica›
tions for the proposed screening programme. Firstly,
information given to women before screening should
seek to normalise and destigmatise chlamydial
infection to reduce the negative psychological impact
of a positive diagnosis. Secondly, although it was clear
that the information given to women by staff served to
lessen, if not eradicate, stigma, disclosure of the condi›
tion to others remained a source of anxiety
(specifically, that others would react badly). This anxiety
may be exacerbated if women feel unable to access
their usual support network. Thus, support services
should be available if required. Women attending a
genitourinary medicine clinic highlighted the impor›
tant role of health advisors in providing advice and
reassurance. Given the uncertainties associated with
chlamydial infection and that reassurance about one
factor can increase anxiety about another, staff outside
specialised services may require guidance in providing
support to women diagnosed with infection. Finally the
chief medical officer’s report recommends that women
with positive diagnoses should be referred to
genitourinary medicine clinics for support and advice
about telling partners. It acknowledges that some
patients may not take up referral and that education is
required to destigmatise genitourinary medicine
services.4 The data reported here support this position.
This is not simply a matter of partner notification;
comorbidity is of concern, and those identified positive
for chlamydia may require a full sexual health screen to
ensure that other infections are diagnosed and
managed appropriately. Genitourinary medicine clin›
ics must be represented as accessible and non›
judgmental sexual health services.
Our data were not from women who had
undergone chlamydia screening as part of a national
screening programme, but these accounts can help
inform our understanding of some of the possible
reactions of women identified through such a
programme to the news that they are infected with C
trachomatis. We do not make any claims regarding the
generalisability of this exploratory study, but, given the
lack of available research in this area, the data provide
important insights. Some of our results echo those of
other studies—for example, the stigma,11 12 and
isolation11 associated with a diagnosis of sexually trans›
mitted infection and relatively low levels of knowledge
of chlamydia.13 It is notable that only six of the women
in the study (three who had attended the genitourinary
medicine clinic and three who had attended the family
planning clinic) had, before diagnosis, perceived them›
selves to be personally vulnerable to a sexually
transmitted infection and had actively sought treat›
ment for this reason. Thus, this sample of women is
unlikely to differ substantially from women recruited to
a national screening programme in terms of perceived
risk of chlamydia, and their reactions to diagnosis (and
to referral to a genitourinary medicine clinic) are likely
to be comparable. A recent study of 20 women who
had been screened for chlamydia in general practice
yielded similar results.14
From the accounts of these women, a diagnosis of
chlamydia triggered rather than allayed uncertainty
about future reproductive morbidity. Current knowl›
edge of the natural course of chlamydia is insufficient
to provide complete reassurance for individual women
about their future reproductive health. It is imperative
that care is taken to ensure that women do not develop
unrealistic expectations of chlamydia screening—for
example, accompanying information should not inad›
vertently imply that diagnosis and treatment of
chlamydia will, in itself, prevent infertility. Indeed, given
the current state of knowledge about chlamydia, some
uncertainty about future reproductive health may be
an inevitable cost of screening for those with positive
diagnoses; this should be made clear to women before
participation.
The proposed chlamydia screening programme
has the laudable public health aim of reducing the
incidence, and possibly eradicating, a treatable sexually
transmitted infection with potentially serious effects on
reproductive health. Before the implementation of any
new national screening programme, however, research
is required to identify strategies to maximise the uptake
of the service while minimising uncertainty and
allaying anxiety associated with positive test results.
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What is already known on this topic
Little is known about the psychosocial
implications of a diagnosis of chlamydia, which is
an important issue in the context of the proposed
UK chlamydia screening programme
What this study adds
Women are concerned about the perceived stigma
of sexually transmitted infections, future
reproductive health, and notifying partners
Messages accompanying screening should not
imply that diagnosis and treatment will prevent
infertility, and uncertainty about future
reproductive morbidity may be an inevitable cost
of screening
Information given to women before screening
should seek to normalise and destigmatise
chlamydial infection to reduce the negative
psychosocial impact of a positive diagnosis
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Birth weight and cognitive function in the British 1946
birth cohort: longitudinal population based study
Marcus Richards, Rebecca Hardy, Diana Kuh, Michael E J Wadsworth
Abstract
Objective To examine the association between birth
weight and cognitive function in the normal
population.
Design A longitudinal, population based, birth cohort
study.
Participants 3900 males and females born in 1946.
Main outcome measures Cognitive function from
childhood to middle life (measured at ages 8, 11, 15,
26, and 43 years).
Results Birth weight was significantly and positively
associated with cognitive ability at age 8 (with an
estimated standard deviation score of 0.44 (95%
confidence interval 0.28 to 0.59)) between the lowest
and highest birthweight categories after sex, father’s
social class, mother’s education, and birth order were
controlled for. This association was evident across the
normal birthweight range ( > 2.5 kg) and so was not
accounted for exclusively by low birth weight. The
association was also observed at ages 11, 15, and 26,
and weakly at age 43, although these associations were
dependent on the association at age 8. Birth weight
was also associated with education, with those of
higher birth weight more likely to have achieved
higher qualifications, and this effect was accounted for
partly by cognitive function at age 8.
Conclusions Birth weight was associated with
cognitive ability at age 8 in the general population,
and in the normal birthweight range. The effect at this
age largely explains associations between birth weight
and cognitive function at subsequent ages. Similarly,
the association between birth weight and education
was accounted for partly by earlier cognitive scores.
Introduction
Small size at birth is associated with a range of adverse
health outcomes,1 including poor cognitive develop›
ment,2 an effect that is largely unconfounded by
features of the family environment, such as socioeco›
nomic status and birth order. Although most cognitive
studies focus on clinically low birthweight groups, con›
firmation of this association across the full birthweight
range in the normal population is of particular interest,
since this would imply that explanatory factors are
similarly distributed in the general population. One
early such population based study found that verbal
reasoning scores at age 11 increased with increasing
birth weight.3 This association was also detected in
early adulthood,4 although not in later life.5
We examined the association between birth weight
and cognitive function in the normal population using
data from the British 1946 birth cohort. A particular
advantage of this cohort is the use of repeated
cognitive assessments throughout life, beginning at age
8 years and extending to age 43, thus allowing the
investigation of relative change in cognitive function
according to birth weight. To investigate an outcome
with specific functional consequences, we also exam›
ined the association between birth weight and
educational attainment.
Methods
The 1946 birth cohort
Participants were drawn from the Medical Research
Council’s national survey of health and development, a
birth cohort study stratified by social class and initially
consisting of 5362 people selected from all births that
occurred in England, Scotland, and Wales during one
week in March 1946.6 Information about socio›
demographic factors and medical, cognitive, and
psychological function has been obtained at intervals
by interview and examination—most recently in 1989
at age 43, when the sample size was 3262; the sample is
regarded as representative of the UK population born
legitimately and singly in the years immediately after
the second world war.7
Cognitive measures and educational attainment
Various cognitive measures were used.8 9 Children were
tested at age 8 on reading comprehension, word
pronunciation, vocabulary, and non›verbal reasoning;
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